Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
If a patient study is renamed on one syngo.Plaza or syngo imaging xs system and sent to another syngo.Plaza or syngo imaging xs system then the entire patient is renamed on the second system. this can cause an unintended merge of patients.